ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
77 hedge funds and large institutions have $247M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+5
Holders Change %
+6.94%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
32
Reduced
16
Closed
10
Calls
$237K
Puts
$1.06M
Net Calls
-$818K
Net Calls Change
-$627K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$3.51M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$2.46M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$1.62M |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.14M |
| 5 |
Goldman Sachs
New York
|
+$1.01M |
Top Sellers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$11.3M |
| 2 |
CC
Casdin Capital
New York
|
-$7.69M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.53M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.01M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$2.78M |
